Benitec Biopharma Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2015 - 2019
Operating Revenue	-	-	0.08	0.07	0.06	0.1	Upgrade
Revenue	-	-	0.08	0.07	0.06	0.1	Upgrade
Revenue Growth (YoY)	-	-	2.74%	23.73%	-42.16%	-99.16%	Upgrade
Cost of Revenue	-	-0.11	-	0.01	0.12	-0.19	Upgrade
Gross Profit	-	0.11	0.08	0.06	-0.06	0.29	Upgrade
Selling, General & Admin	11.99	6.99	6.38	6.65	6.51	5.57	Upgrade
Research & Development	18.15	15.61	12.77	11.27	7.02	3	Upgrade
Operating Expenses	30.14	22.6	19.16	17.92	13.53	8.57	Upgrade
Operating Income	-30.14	-22.49	-19.08	-17.85	-13.6	-8.28	Upgrade
Interest Expense	-	-	-0.03	-0.03	-0.01	-	Upgrade
Interest & Investment Income	3.17	0.9	-	-	-	0.06	Upgrade
Currency Exchange Gain (Loss)	-0.13	0.04	-0.42	-0.23	-0.33	-0.09	Upgrade
Other Non Operating Income (Expenses)	-0.16	-0.2	-0.03	-0.08	-	-	Upgrade
EBT Excluding Unusual Items	-27.25	-21.75	-19.56	-18.2	-13.94	-8.31	Upgrade
Gain (Loss) on Sale of Investments	-	-0	-0	-0.01	0.02	-0	Upgrade
Other Unusual Items	0.76	-	-	-	0.04	0.03	Upgrade
Pretax Income	-26.49	-21.75	-19.56	-18.21	-13.88	-8.27	Upgrade
Net Income	-26.49	-21.75	-19.56	-18.21	-13.88	-8.27	Upgrade
Preferred Dividends & Other Adjustments	-	0.62	-	-	-	-	Upgrade
Net Income to Common	-26.49	-22.37	-19.56	-18.21	-13.88	-8.27	Upgrade
Shares Outstanding (Basic)	18	4	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	18	4	1	0	0	0	Upgrade
Shares Change (YoY)	46.71%	192.98%	188.30%	90.24%	320.63%	19.19%	Upgrade
EPS (Basic)	-1.47	-5.51	-14.12	-37.88	-54.94	-137.74	Upgrade
EPS (Diluted)	-1.47	-5.51	-14.12	-37.88	-54.94	-137.74	Upgrade
Free Cash Flow	-18.69	-19.58	-18.01	-15.91	-13.05	-7.63	Upgrade
Free Cash Flow Per Share	-1.03	-4.82	-13.00	-33.10	-51.66	-127.02	Upgrade
Gross Margin	-	-	100.00%	87.67%	-108.47%	281.37%	Upgrade
Operating Margin	-	-	-25441.33%	-24457.53%	-23044.07%	-8118.63%	Upgrade
Profit Margin	-	-	-26082.67%	-24942.47%	-23528.81%	-8111.76%	Upgrade
Free Cash Flow Margin	-	-	-24017.33%	-21797.26%	-22123.73%	-7480.39%	Upgrade
EBITDA	-30.06	-22.4	-18.95	-17.69	-13.37	-8.09	Upgrade
D&A For EBITDA	0.08	0.09	0.14	0.17	0.23	0.19	Upgrade
EBIT	-30.14	-22.49	-19.08	-17.85	-13.6	-8.28	Upgrade
Revenue as Reported	-	-	-	-	-	0.1	Upgrade

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q